About Artin Bioscience
Artin Bioscience is a private company based in Denver, Colorado, incorporated in 2021 in Delaware. It has reported $482,500 raised in one offering on Form D since March 2023. Its chief executive is Charles Magolske.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 1, 2023 | Mar 13, 2023 | $482,500fully sold | 0 | — | EquityRule 506(c) | Form D ↗ |
The filing for the offering first filed Mar 13, 2023 reports amount sold with no investors. Figures are shown as filed.
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Artin Bioscience's Form D filed Mar 13, 2023.
DD
David Doyle
Executive officer and director
EE
Erik Eglite
Executive officer and director
CM
Charles Magolske
Chief Executive Officer and director
NV
Norbert Voelkel
Director